Leerink Partnrs Analysts Raise Earnings Estimates for Waters

Waters Co. (NYSE:WAT) – Research analysts at Leerink Partnrs upped their Q3 2025 EPS estimates for shares of Waters in a note issued to investors on Wednesday, February 12th. Leerink Partnrs analyst P. Souda now forecasts that the medical instruments supplier will post earnings of $3.20 per share for the quarter, up from their previous forecast of $3.12. The consensus estimate for Waters’ current full-year earnings is $11.79 per share. Leerink Partnrs also issued estimates for Waters’ Q1 2026 earnings at $2.45 EPS, Q2 2026 earnings at $3.21 EPS, Q3 2026 earnings at $3.62 EPS and Q4 2026 earnings at $4.77 EPS.

Waters (NYSE:WAT) last announced its quarterly earnings data on Wednesday, February 12th. The medical instruments supplier reported $4.10 earnings per share (EPS) for the quarter, beating the consensus estimate of $4.02 by $0.08. Waters had a net margin of 21.43% and a return on equity of 49.93%.

Other analysts have also recently issued reports about the stock. Scotiabank raised shares of Waters from a “sector perform” rating to a “sector outperform” rating and boosted their price objective for the company from $430.00 to $450.00 in a research note on Thursday. TD Cowen boosted their price objective on shares of Waters from $363.00 to $410.00 and gave the company a “hold” rating in a research note on Monday, November 4th. Deutsche Bank Aktiengesellschaft upped their price target on shares of Waters from $310.00 to $325.00 and gave the stock a “hold” rating in a research report on Monday, November 4th. UBS Group upped their price target on shares of Waters from $405.00 to $410.00 and gave the stock a “neutral” rating in a research report on Thursday. Finally, Stifel Nicolaus upped their price target on shares of Waters from $332.00 to $360.00 and gave the stock a “hold” rating in a research report on Monday, November 4th. Ten equities research analysts have rated the stock with a hold rating, five have issued a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $390.40.

Waters Stock Down 2.5 %

Shares of NYSE WAT opened at $369.71 on Friday. Waters has a 52-week low of $279.24 and a 52-week high of $423.56. The firm has a fifty day moving average of $389.84 and a 200-day moving average of $364.30. The stock has a market capitalization of $21.95 billion, a PE ratio of 35.28, a P/E/G ratio of 7.37 and a beta of 1.01. The company has a quick ratio of 1.38, a current ratio of 2.02 and a debt-to-equity ratio of 1.14.

Hedge Funds Weigh In On Waters

Institutional investors have recently added to or reduced their stakes in the company. Aster Capital Management DIFC Ltd acquired a new stake in shares of Waters in the 4th quarter valued at about $28,000. Kennebec Savings Bank acquired a new stake in shares of Waters in the 3rd quarter valued at about $33,000. Bank of Jackson Hole Trust acquired a new stake in shares of Waters in the 4th quarter valued at about $34,000. Ashton Thomas Securities LLC acquired a new stake in shares of Waters in the 3rd quarter valued at about $35,000. Finally, Fortitude Family Office LLC raised its stake in shares of Waters by 235.7% in the 4th quarter. Fortitude Family Office LLC now owns 94 shares of the medical instruments supplier’s stock valued at $35,000 after purchasing an additional 66 shares in the last quarter. Institutional investors and hedge funds own 94.01% of the company’s stock.

About Waters

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.